MNOV — Medicinova Cashflow Statement
0.000.00%
Last trade - 00:00- $73.34m
- $42.53m
- $0.41m
Annual cashflow statement for Medicinova, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -10.1 | -14.1 | -8.57 | -11 | -12 |
| Depreciation | |||||
| Non-Cash Items | 1.93 | 0.806 | 1.01 | 1.37 | 1 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.21 | 0.334 | 0.112 | -0.98 | 1.17 |
| Change in Prepaid Expenses | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -9.38 | -12.9 | -7.43 | -10.6 | -9.81 |
| Capital Expenditures | -0.029 | -0.005 | -0.021 | -0.001 | -0.003 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | -40 | 39.9 | 0 | 0 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.029 | -40 | 39.9 | -0.001 | -0.003 |
| Financing Cash Flow Items | -0.118 | 0 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 20.8 | 0.008 | 0 | — | 0.244 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 11.4 | -52.9 | 32.5 | -10.6 | -9.55 |